Zibar K - Search Results

1

[Lysosomal acid lipase deficiency in children: our experience and a novel possibility of enzyme replacement therapy].

Ramadža DP, Ćuk M, Zibar K, Barić M, Sarnavka V, Bilić K, Fumić K, Vuković J, Pušeljić S, Ćorić M, Padovan RŠ, Kralik M, Barić I. Ramadža DP, et al. Among authors: zibar k. Lijec Vjesn. 2015 Mar-Apr;137(3-4):81-7. Lijec Vjesn. 2015. PMID: 26065284 Croatian.

2

Authors' response.

Zibar K, Barić I. Zibar K, et al. J Pediatr Gastroenterol Nutr. 2013 Sep;57(3):e19. doi: 10.1097/MPG.0b013e31829a500d. J Pediatr Gastroenterol Nutr. 2013. PMID: 23666456 No abstract available.

3

Glyceroluria and neonatal hemochromatosis.

Barić I, Zibar K, Ćorić M, Santer R, Bonilla S, Bilić K, Buljević AD, Benjak V, Fumić K, Whitington PF. Barić I, et al. Among authors: zibar k. J Pediatr Gastroenterol Nutr. 2012 Oct;55(4):e126-8. doi: 10.1097/MPG.0b013e3182347a26. J Pediatr Gastroenterol Nutr. 2012. PMID: 21886008 No abstract available.

4

Incretin based therapies: a novel treatment approach for non-alcoholic fatty liver disease.

Blaslov K, Bulum T, Zibar K, Duvnjak L. Blaslov K, et al. Among authors: zibar k. World J Gastroenterol. 2014 Jun 21;20(23):7356-65. doi: 10.3748/wjg.v20.i23.7356. World J Gastroenterol. 2014. PMID: 24966606 Free PMC article. Review.

5

Effect of exenatide therapy on hepatic fat quantity and hepatic biomarkers in type 2 diabetic patients.

Blaslov K, Zibar K, Bulum T, Duvnjak L. Blaslov K, et al. Among authors: zibar k. Clin Res Hepatol Gastroenterol. 2014 Jun;38(3):e61-3. doi: 10.1016/j.clinre.2013.10.013. Epub 2013 Dec 4. Clin Res Hepatol Gastroenterol. 2014. PMID: 24315013 No abstract available.

6

Difference in glucagon-like peptide-1 concentrations between C-peptide negative type 1 diabetes mellitus patients and healthy controls.

Zibar K, Ćuća JK, Blaslov K, Bulum T, Smirčić-Duvnjak L. Zibar K, et al. Ann Clin Biochem. 2015 Mar;52(Pt 2):220-5. doi: 10.1177/0004563214544709. Epub 2014 Jul 8. Ann Clin Biochem. 2015. PMID: 25005458 Free article.

7

Relationship between metabolic syndrome and meal-induced glucagon like peptide-1 response in type 1 diabetic patients1-1.

Blaslov K, Bulum T, Zibar K, Duvnjak L. Blaslov K, et al. Among authors: zibar k. J Diabetes. 2015 May;7(3):340-6. doi: 10.1111/1753-0407.12194. Epub 2014 Oct 3. J Diabetes. 2015. PMID: 25042812

8

Basal and postprandial change in serum fibroblast growth factor-21 concentration in type 1 diabetic mellitus and in healthy controls.

Zibar K, Blaslov K, Bulum T, Ćuća JK, Smirčić-Duvnjak L. Zibar K, et al. Endocrine. 2015 Apr;48(3):848-55. doi: 10.1007/s12020-014-0413-9. Epub 2014 Sep 7. Endocrine. 2015. PMID: 25194937

9

Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.

Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Haahr PM, Lange M, Brown-Frandsen K, Moses A, Skibsted S, Kvist K, Buse JB; DEVOTE Study Group. Marso SP, et al. N Engl J Med. 2017 Aug 24;377(8):723-732. doi: 10.1056/NEJMoa1615692. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605603 Free PMC article. Clinical Trial.

10

Relationship between Adiponectin Level, Insulin Sensitivity, and Metabolic Syndrome in Type 1 Diabetic Patients.

Blaslov K, Bulum T, Zibar K, Duvnjak L. Blaslov K, et al. Among authors: zibar k. Int J Endocrinol. 2013;2013:535906. doi: 10.1155/2013/535906. Epub 2013 Jul 17. Int J Endocrinol. 2013. PMID: 23956744 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters